Metastatic melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
504
|
42
|
0.300 |
None |
|
0 |
|
|
|
Adenocarcinoma of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
342
|
108
|
0.300 |
None |
|
0 |
|
|
|
Adenocarcinoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
543
|
432
|
0.300 |
None |
|
0 |
|
|
|
COLON CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Mammary Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
218
|
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Mammary Neoplasms, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
527
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Kidney Neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
295
|
11
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Mammary Carcinoma, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
545
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Chromosomal Instability
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Cell or Molecular Dysfunction
|
8
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Aneuploidy
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Cell or Molecular Dysfunction
|
5
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Malignant neoplasm of kidney
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
664
|
22
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Peripheral Nervous System Diseases
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
549
|
69
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Finding of Mean Corpuscular Hemoglobin
|
phenotype |
|
Finding
|
653
|
1206
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Childhood Malignant Peripheral Nerve Sheath Tumor
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
62
|
2
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Prostatic Intraepithelial Neoplasias
|
disease |
Neoplasms
|
Neoplastic Process
|
230
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Childhood Acute Monoblastic Leukemia
|
disease |
|
Neoplastic Process
|
19
|
5
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Uterine Carcinosarcoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
41
|
80
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
296
|
9
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
invasive cancer
|
phenotype |
Neoplasms
|
Neoplastic Process
|
146
|
15
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Aggressive Adult Non-Hodgkin Lymphoma
|
disease |
|
Neoplastic Process
|
16
|
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Carcinoma of larynx
|
disease |
Neoplasms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
456
|
65
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Recurrent tumor
|
phenotype |
|
Neoplastic Process
|
735
|
33
|
0.010 |
None |
1.000 |
1 |
1
|
2007 |
2007 |
Secondary malignant neoplasm of liver
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
951
|
34
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Acute monoblastic leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
37
|
5
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |